160 related articles for article (PubMed ID: 33803915)
21. How deep is too deep? Assessing myometrial invasion as a predictor of distant recurrence in stage I endometrioid endometrial cancer.
Dinoi G; Garzon S; Weaver A; McGree M; Glaser G; Langstraat C; Kumar A; Weroha J; Garda AE; Shahi M; Palmieri E; Scambia G; Fanfani F; Mariani A
Int J Gynecol Cancer; 2024 May; ():. PubMed ID: 38821549
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of Adjuvant Therapy for Stage IA Serous Endometrial Cancer.
Donovan E; Reade CJ; Eiriksson LR; Pond GR; Arora N; Elit L; Memon S; Voruganti S; Patel M; Jimenez W; John M; Kong I
Cureus; 2018 Sep; 10(9):e3387. PubMed ID: 30524915
[TBL] [Abstract][Full Text] [Related]
23. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
24. Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?
Crosby MA; Tward JD; Szabo A; Lee CM; Gaffney DK
Am J Clin Oncol; 2010 Aug; 33(4):364-9. PubMed ID: 20689365
[TBL] [Abstract][Full Text] [Related]
25. Does the type of surgery for early-stage endometrial cancer affect the rate of reported lymphovascular space invasion in final pathology specimens?
Momeni M; Kolev V; Cardenas-Goicoechea J; Getrajdman J; Fishman D; Chuang L; Kalir T; Rahaman J; Zakashansky K
Am J Obstet Gynecol; 2013 Jan; 208(1):71.e1-6. PubMed ID: 23099190
[TBL] [Abstract][Full Text] [Related]
26. Value of combined adjuvant chemotherapy and radiation on survival for stage III uterine cancer: is less radiation equal to more?
Wang CJ; Christie A; Folkert MR; Xie XJ; Albuquerque K
J Gynecol Oncol; 2018 Jul; 29(4):e49. PubMed ID: 29770620
[TBL] [Abstract][Full Text] [Related]
27. Retrospective Analysis of All Types of Adjuvant Radiotherapy in Endometrial Cancer: Single-Center Experiences in a Middle-Income Country.
Chitapanarux N; Tharavichitkul E; Kittidachanan K; Muangwong P; Chakrabandhu S; Klunklin P; Onchan W; Jia-Mahasap B; Torapichattrakul P; Chitapanarux I
Asian Pac J Cancer Prev; 2024 Feb; 25(2):485-494. PubMed ID: 38415534
[TBL] [Abstract][Full Text] [Related]
28. Survival and disease relapse in surgical stage I endometrioid adenocarcinoma of the uterus after adjuvant vaginal vault brachytherapy.
Kumar VJ; Nin CY; Kuei LY; Tan KH; Yeo R; Lam PY
Int J Gynecol Cancer; 2010 May; 20(4):564-9. PubMed ID: 20686374
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis.
Kong A; Johnson N; Kitchener HC; Lawrie TA
J Natl Cancer Inst; 2012 Nov; 104(21):1625-34. PubMed ID: 22962693
[TBL] [Abstract][Full Text] [Related]
30. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
31. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
32. Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer?
Greven KM; D'Agostino RB; Lanciano RM; Corn BW
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):101-4. PubMed ID: 9747826
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma.
Nagar H; Yan W; Parashar B; Nori D; Chao KS; Christos P; Gupta D; Holcomb K; Caputo T; Wernicke AG
Am J Clin Oncol; 2016 Aug; 39(4):335-9. PubMed ID: 27028349
[TBL] [Abstract][Full Text] [Related]
34. Impact of adjuvant treatment on survival in patients with 2023 FIGO stage IIC endometrial cancer: a retrospective analysis from two tertiary centers in Korea and Taiwan.
Lee YY; Lai YL; Kim MS; Chang K; Kim HS; Cheng WF; Chen YL
J Gynecol Oncol; 2024 May; 35(3):e33. PubMed ID: 38130137
[TBL] [Abstract][Full Text] [Related]
35. Postoperative radiotherapy in intermediate and high-risk Stage I endometrial cancer: analysis of prognostic factors and survival.
Bolukbasi Y; Demirci S; Ozsaran Z; Yalman D; Hanhan M; Ozsaran A; Dikmen Y; Aras A
Eur J Gynaecol Oncol; 2008; 29(5):505-10. PubMed ID: 19051823
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of adjuvant vaginal vault brachytherapy in early stage cervical cancer patients.
Bronsart E; Petit C; Gouy S; Bockel S; Espenel S; Kumar T; Fumagalli I; Maulard A; Ayachy RE; Genestie C; Leary A; Pautier P; Morice P; Haie-Meder C; Chargari C
Cancer Radiother; 2020 Dec; 24(8):860-865. PubMed ID: 33129715
[TBL] [Abstract][Full Text] [Related]
37. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study.
Sorbe B; Horvath G; Andersson H; Boman K; Lundgren C; Pettersson B
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1249-55. PubMed ID: 21676554
[TBL] [Abstract][Full Text] [Related]
38. Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer.
Weinberg LE; Kunos CA; Zanotti KM
Int J Gynecol Cancer; 2013 Oct; 23(8):1438-45. PubMed ID: 24257558
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis.
Rossi PJ; Jani AB; Horowitz IR; Johnstone PA
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):134-8. PubMed ID: 17855014
[TBL] [Abstract][Full Text] [Related]
40. Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma.
Xiang M; English DP; Kidd EA
Gynecol Oncol; 2019 Sep; 154(3):487-494. PubMed ID: 31257010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]